New in CME Courses: Considerations in the Use of GLP-1 RA and Basal Insulin in Clinical Practice

Target audience:  Primary Care Providers, Nurse Practitioners, Physician Assistants.


Patients with type 2 diabetes (T2DM) represent a common clinical challenge for primary care clinicians. Despite its high prevalence, T2DM is typically poorly managed. Clinicians and patients often resist or neglect the intensification of medical therapy to achieve and maintain glycemic targets, sometimes for many years. Without adequate glycemic control, these patients remain at elevated risk for serious complications of diabetes.
The good news is that new agents and combinations of agents – such as SGLT-2 inhibitors, DPP-4 inhibitors, GLP-1 receptor agonists (RA), and fixed-ratio basal insulin/GLP-1 RAs – expand the therapeutic options to manage hyperglycemia, often with lower risk for some of the common side effects of antihyperglycemic therapy.
In this unique game-style activity, you will participate in the management of a virtual patient and rank therapeutic options at each decision point. Expert faculty will rank the same options and provide an evidence-based rationale for their choices.


This activity, Considerations in the Use of GLP-1 RA and Basal Insulin in Clinical Practice offers 0.75 AMA PRA Category 1 Credit™.

Click here to start this engaging activity!